ReP USP - Resultado da busca

Filtros : "HIDROXILASE (ATIVIDADE)" Limpar

Filtros

Artigo de periodico
CYP21A2 Genotypes do not Predict the Severity of Hyperandrogenic Manifestations in the Nonclassical Form of Congenital Adrenal Hyperplasia (2013)
Moura-Massari, V. O.; Bugano, D. D. G.; Marcondes, J. A. M.; Gomes, L. G.; Mendonca, B. B.; Bachega, T. A. S. S.
Source: Hormone and Metabolic Research. Unidade: FM
Subjects: HIPERPLASIA SUPRARRENAL CONGÊNITA, HIDROXILASE (ATIVIDADE), FENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOURA-MASSARI, V. O. et al. CYP21A2 Genotypes do not Predict the Severity of Hyperandrogenic Manifestations in the Nonclassical Form of Congenital Adrenal Hyperplasia. Hormone and Metabolic Research, v. 5, p. (online), 2013Tradução . . Disponível em: https://doi.org/10.1055/s-0032-1330007. Acesso em: 12 fev. 2026.
APA
Moura-Massari, V. O., Bugano, D. D. G., Marcondes, J. A. M., Gomes, L. G., Mendonca, B. B., & Bachega, T. A. S. S. (2013). CYP21A2 Genotypes do not Predict the Severity of Hyperandrogenic Manifestations in the Nonclassical Form of Congenital Adrenal Hyperplasia. Hormone and Metabolic Research, 5, (online). doi:10.1055/s-0032-1330007
NLM
Moura-Massari VO, Bugano DDG, Marcondes JAM, Gomes LG, Mendonca BB, Bachega TASS. CYP21A2 Genotypes do not Predict the Severity of Hyperandrogenic Manifestations in the Nonclassical Form of Congenital Adrenal Hyperplasia [Internet]. Hormone and Metabolic Research. 2013 ; 5 (online).[citado 2026 fev. 12 ] Available from: https://doi.org/10.1055/s-0032-1330007
Vancouver
Moura-Massari VO, Bugano DDG, Marcondes JAM, Gomes LG, Mendonca BB, Bachega TASS. CYP21A2 Genotypes do not Predict the Severity of Hyperandrogenic Manifestations in the Nonclassical Form of Congenital Adrenal Hyperplasia [Internet]. Hormone and Metabolic Research. 2013 ; 5 (online).[citado 2026 fev. 12 ] Available from: https://doi.org/10.1055/s-0032-1330007
Artigo de periodico
Substitutions in the CYP21A2 promoter explain the simple-virilizing form of 21-hydroxylase deficiency in patients harbouring a P30L mutation (2005)
Araujo, Rogério S.; Billerbeck, Ana Elisa C.; Madureira, Guiomar; Mendonça, Berenice Bilharinho; Bachega, Tânia A. S. S.
Source: Clinical Endocrinology. Unidade: FM
Subjects: FENÓTIPOS, HIPERPLASIA SUPRARRENAL CONGÊNITA, HIDROXILASE (ATIVIDADE)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAUJO, Rogério S. et al. Substitutions in the CYP21A2 promoter explain the simple-virilizing form of 21-hydroxylase deficiency in patients harbouring a P30L mutation. Clinical Endocrinology, v. 62, p. 132-136, 2005Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2265.2005.02184.x. Acesso em: 12 fev. 2026.
APA
Araujo, R. S., Billerbeck, A. E. C., Madureira, G., Mendonça, B. B., & Bachega, T. A. S. S. (2005). Substitutions in the CYP21A2 promoter explain the simple-virilizing form of 21-hydroxylase deficiency in patients harbouring a P30L mutation. Clinical Endocrinology, 62, 132-136. doi:10.1111/j.1365-2265.2005.02184.x
NLM
Araujo RS, Billerbeck AEC, Madureira G, Mendonça BB, Bachega TASS. Substitutions in the CYP21A2 promoter explain the simple-virilizing form of 21-hydroxylase deficiency in patients harbouring a P30L mutation [Internet]. Clinical Endocrinology. 2005 ; 62 132-136.[citado 2026 fev. 12 ] Available from: https://doi.org/10.1111/j.1365-2265.2005.02184.x
Vancouver
Araujo RS, Billerbeck AEC, Madureira G, Mendonça BB, Bachega TASS. Substitutions in the CYP21A2 promoter explain the simple-virilizing form of 21-hydroxylase deficiency in patients harbouring a P30L mutation [Internet]. Clinical Endocrinology. 2005 ; 62 132-136.[citado 2026 fev. 12 ] Available from: https://doi.org/10.1111/j.1365-2265.2005.02184.x

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2026